Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 17, 10:01
Statera BioPharma Cash from Financing (Quarterly): 0.7117M for Sept. 30, 2022
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.7117M |
| June 30, 2022 | 0.5001M |
| March 31, 2022 | -2.898M |
| December 31, 2021 | 0.0894M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.6718M |
| June 30, 2021 | 18.07M |
| March 31, 2021 | 2.155M |
| March 31, 2020 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.898M
Minimum
Mar 2022
18.07M
Maximum
Jun 2021
2.413M
Average
0.586M
Median
Cash from Financing (Quarterly) Benchmarks
| Humanigen Inc | 0.00 |
| Cannabis Global Inc | -0.156M |
| Item 9 Labs Corp | -0.005M |
| Cantabio Pharmaceuticals Inc | 0.52M |
| Affymax Inc | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.8015M |